Mississippi Medicaid and semaglutide
Wegovy for weight loss: yes. Listed in the antiobesity class with manual prior authorization and review after 12 months. BMI rules were not readable. Ozempic for weight loss: unclear; for type 2 diabetes Mississippi Medicaid must cover it. Read from Mississippi Division of Medicaid documents Nov 6, 2026.
In 2025 Mississippi Medicaid paid for 34,405 semaglutide prescriptions (Wegovy, Ozempic, Rybelsus), 56% of its GLP-1 prescriptions and 28th of the 50 states and DC. It reimbursed $44.1 million before rebates, $1,282 a prescription against $1,104 nationally.
| Brand | Prescriptions | Medicaid paid | Per Rx |
|---|---|---|---|
| Wegovy | 31,785 | $41.5 million | $1,307 |
| Ozempic | 2,491 | $2.5 million | $989 |
| Rybelsus | 129 | $126,642 | $982 |
Mississippi plans and prescribing rules
Mississippi State and School Employees' Health Insurance Plan. Mississippi's State and School Employees' plan excludes Wegovy and other drugs used for weight loss or obesity. Wegovy and Zepbound are considered only for their other FDA-approved uses, such as obstructive sleep apnea for Zepbound.
Semaglutide in the states around Mississippi
| State | Sell semaglutide, ship there | Cheapest | Medicaid Rx, 2025 | Medicaid, Wegovy for weight loss |
|---|---|---|---|---|
| Mississippi | 15 | $39/moWellmedr | 34,405 | Medicaid Wegovy: Yes |
| Alabama | 15 | $39/moWellmedr | 35,802 | Medicaid Wegovy: No |
| Arkansas | 16 | $39/moWellmedr | 4,707 | Medicaid Wegovy: No |
| Louisiana | 13 | $39/moWellmedr | 106,773 | Medicaid Wegovy: No |
| Tennessee | 18 | $39/moWellmedr | 86,329 | Medicaid Wegovy: Yes |



